BSXbenzinga

Boston Scientific Raises FY2025 Adj EPS Guidance from $2.80-$2.87 to $2.87-$2.94 vs $2.86 Est and estimate net sales growth for the full year 2025 to be approximately 15 to 17 percent versus the prior year period

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 23, 2025 by benzinga